Content
Search
Navigation
Sitemap
About us
Pipeline & science
Overview
Obesity
Type 2 Diabetes Mellitus (T2DM)
Acute Ischemic Stroke (AIS)
Hypertension
Our expertise
Overview
Our strategic partners
Global opportunities
Join us
Press releases
Contact
简体中文
Search
简体中文
Navigation
Press releases
11 Jan 2024
JIXING Acquires BIIB131 from Biogen to Treat Acute Ischemic Stroke
Read article
11 Jan 2024
TMS and JIXING Announce a Series of Strategic Collaborations
Read article
06 Jan 2024
Bayer and RTW Investments Lead Series D Financing in Chinese biotech Ji Xing Pharmaceuticals
Read article
03 Jan 2024
JIXING Announces TFDA Acceptance of New Drug Application for Varenicline Solution Nasal Spray for the Taiwan Region
Read article
30 Dec 2023
JIXING Announces Positive Results From The China Cohort Of SEQUOIA-HCM, The Pivotal Phase 3 Clinical Trial Of Aficamten In Patients With Obstructive Hypertrophic Cardiomyopathy
Read article
27 Dec 2023
Cytokinetics Announces Positive Results From SEQUOIA-HCM, the Pivotal Phase 3 Clinical Trial of Aficamten in Patients With Obstructive Hypertrophic Cardiomyopathy
Read article
Load more
